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Abstract H19 and Igf2 are linked and reciprocally imprinted
genes. We demonstrate that the histones associated with the
paternally inherited and unexpressed H19 allele are less
acetylated than those associated with the maternal expressed
allele. Cell growth in the presence of inhibitors of either histone
deacetylase or DNA methylation activated the silent Igf2 allele,
whereas derepression of the silent HI9 allele required combined
inhibition of DNA methylation and histone deacetylation. Our
results indicate that histone acetylation as well as DNA
methylation contribute to the somatic maintenance of H19 and
Igf2 imprinting and that silencing of the imprinted alleles of these
two genes is maintained via distinct mechanisms.
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1. Introduction
A subset of genes present in diploid organisms display dif-
ferential expression of the two alleles. Those whose expression
is dependent on the parental origin of the allele are known as
imprinted genes. The imprint is an epigenetic modi¢cation
established during gametogenesis in a sex-speci¢c manner,
transmitted into the zygote and maintained in the embryo
through cell generations, then erased in the germ line in order
to be replaced by a new one. The nature of the imprint and
the mechanism by which it causes preferential expression of
one allele are still unde¢ned. DNA methylation is certainly
involved in at least one of the steps of the imprinting process,
since imprinted genes show CpG sites which are di¡erentially
methylated on paternal and maternal alleles and mouse em-
bryos de¢cient in DNA methyltransferase activity have lost
genomic imprinting [1,2]. However, a few imprinted genes lack
di¡erential methylation or are una¡ected by disruption of the
DNA methyltransferase gene and many allele-speci¢c methyl-
ations are not conserved throughout development, suggesting
that other kinds of epigenetic modi¢cations may contribute to
this phenomenon as well.
In addition to DNA methylation, another epigenetic mod-
i¢cation that may modulate transcription in the chromatin
context is histone acetylation. Lysines at the N-terminal tails
of core histones may be acetylated, particularly within nucle-
osomes associated with transcribed genes [3]. Conversely, in-
active genomic regions, such as the silent X chromosome and
constitutive heterochromatin, are associated with hypoacety-
lated histones. It has been suggested that acetylation alters
nucleosome conformation by decreasing the a⁄nity of his-
tones for DNA or causes a change in the higher-order chro-
matin structure by interfering with the internucleosomal con-
tacts [4]. DNA hypermethylation can cause a decrease in the
level of histone acetylation [5], consistent with recent demon-
strations of an interaction between the methyl binding protein
MeCP2 and histone deacetylase [6,7].
A cluster of imprinted genes is located on the distal portion
of mouse chromosome 7 and the homologous human region
on chromosome 11p15.5 [8]. The insulin-like growth factor-2
(Igf2) and H19 genes are located in this region, separated by
75 kb and imprinted in a reciprocal manner. Igf2 is expressed
exclusively from the chromosome of paternal origin and H19
is expressed only from the maternal allele. The H19 gene is
included in a 7^9 kb region, which is hypermethylated on the
inactive allele, and its promoter displays an open chromatin
conformation only on the expressed allele [9,10]. In contrast
to the di¡erential methylation of the H19 gene, only limited
di¡erences in the extent of methylation at a few CpG sites
distant from the promoters and similar nuclease sensitivity
have been found between paternal and maternal alleles of
the Igf2 gene [11^13]. The expression of the Igf2 and H19
genes is linked and dependent on common regulatory ele-
ments [14,15].
In this paper, we show that di¡erentially acetylated histones
are associated with paternal and maternal alleles of the H19
gene in cultured mouse ¢broblasts, such that the silent allele is
hypoacetylated. No di¡erences in the relative histone acetyla-
tion levels of the two parental Igf2 alleles were found in the 3P
untranslated region (UTR) and 700 bp 5P of promoter P2.
However, treatment of the cells with histone deacetylase in-
hibitors caused relaxation of Igf2 imprinting, an e¡ect that
was additive to that obtained with the cytosine methylation
inhibitor 5-aza-2P-deoxycytidine (5-azaC). Little or no e¡ect
of the histone deacetylase or DNA methylation inhibitors
alone was observed on H19 imprinting, but the combination
of both did reactivate the silent H19 allele. These results in-
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dicate that both DNA methylation and histone acetylation
contribute to the maintenance of the imprinting status of
the H19 and Igf2 genes and that inhibition of both types of
epigenetic modi¢cations is required to activate the imprinted
H19 allele.
2. Materials and methods
2.1. Cell cultures
Mice of BALB/c and C57-Black6 strains were obtained from
Charles River Italia. The cells were derived from a 3-day-old animal
generated from a cross between a BALB/c father and a Black6 moth-
er. Primary cultures of ¢broblast cells were obtained as previously
described [16]. The expression of Igf2/H19 genes in these cells was
estimated to be at least 50-fold higher than that of adult liver and
about one tenth that of fetal (E20) liver (data not shown). Igf2/H19
expression was maintained in these cultured cells at least until the
tenth passage. For the analysis of histone deacetylase inhibitors,
fourth- or ¢fth-passage cells were plated at a seeding density of
5U105 cells/dish. Two days after seeding, culture medium was re-
placed with medium containing the histone deacetylase inhibitors so-
dium butyrate or trichostatin A (TSA) at the indicated concentra-
tions. Twenty-four hours later, RNA was harvested from the cells.
In order to test the e¡ect of 5-azaC and 5-azaC plus histone de-
acetylase inhibitors, ¢fth-passage cells were plated at a density of
4U105 cells/dish. Twenty-four hours later, 100 or 200 WM 5-azaC
was added to the cells. Medium with freshly added 5-azaC was
changed on the third and ¢fth day of culture. On the sixth day, where
indicated, 100 ng/ml TSA or 50 mM sodium butyrate was added still
in the presence of 5-azaC. Twenty-four hours later all the cells were
harvested and analyzed.
2.2. Histone acetylation analysis
Nuclei for chromatin immunoprecipitation were prepared by lysing
cells in 10 mM Tris, 10 mM NaCl, 3 mM MgCl2, and 0.4% NP-40.
Nuclei were washed and digested in the same bu¡er with micrococcal
nuclease for 10 min at a concentration experimentally determined to
give a mostly mononucleosomal chromatin preparation. 100 Wg of
chromatin prepared in this way was immunoprecipitated with 20 Wg
of antibody (Upstate Biotechnology, Lake Placid, NY, USA) against
acetylated H3 or H4 tail peptides as described [17]. The antibody
recognized di- and tetraacetylated lysine epitopes of histones H3
and H4, respectively. In a control experiment without primary anti-
body, only a small fraction of the DNA obtained with either anti-
acetylated H3 or H4 antibody added was pulled down with the pro-
tein A agarose beads (data not shown). Di¡erential allelic acetylation
was detected by quantitative ampli¢cation of 5 ng of immunoprecipi-
tated DNA using PCR primers which distinguish the BALB/c and
Black6 haplotypes either directly as a length polymorphism or by
restriction enzyme digestion following ampli¢cation. In all reactions,
a trace amount of one 32P-end labelled primer was included and
visualization of ampli¢ed products took place on a phosphorimager,
allowing relative allelic intensities to be measured.
Immunoprecipitated DNA at the 3P position of the Igf2 gene was
detected by ampli¢cation with primer pairs Igf2-C (5P-GATTATACT-
CACACCACAGGC-3P) and Igf2-D (5P-CATCCAATTATGTGGG-
TGTGC-3P) followed by separation on an 8% denaturing polyacryl-
amide sequencing gel, allowing detection of paternal and maternal
products which are approximately 115 bp in length but di¡er by 8^
12 bp [18]. Analysis of the H19 promoter region was performed by
ampli¢cation with primers H19-C (5P-GGCAGGATAGTTAGCA-
AAGG-3P) and H19-B (5P-CCTCAGTCTTTACTGGCAAC-3P).
Products of the H19 ampli¢cation were incubated with the restriction
endonuclease MspI, which produces a radiolabelled 76 bp digested
paternal fragment and leaves a 139 bp undigested maternal band
following electrophoresis as above [19]. DNA from the two alleles
at the Igf2 promoter region was ampli¢ed with the primer pair Igf2-
E (5P-GGTTTGAGCTACGTTTCCCG-3P) and Igf2-F (5P-ATCTCC-
TAGCAGCCTTTGGG-3P) and digestion of the products with AvaII
restriction endonuclease. Electrophoresis of the AvaII digest separated
a 74 bp digested maternal fragment and a 149 bp undigested paternal
band. All PCRs were carried out in 5 Wl reactions using an initial
denaturation at 94 C for 1 min, then 35 cycles at 94‡C, 30 s; 62‡C,
30 s; and 72‡C, 30 s. As controls for ampli¢cation, analyses were also
performed on puri¢ed parental BALB/c and C57-Black6 DNA. Addi-
tionally, control reactions were performed on ranges of stoichiometric
mixtures of parental DNAs to ensure that the ratios of ¢nal products
detected accurately re£ected the relative concentrations of the alleles
in the input DNA.
2.3. Isolation of DNA and RNA
Genomic DNA was prepared from cells by proteinase K digestion
and phenol-chloroform extraction methods [20]. Total RNA was iso-
lated using the single-step acid guanidinium thiocyanate-phenol-
chloroform extraction method [21].
2.4. RT-PCR analysis
For detection of the expressed alleles, 0.5^1 Wg total RNA was ¢rst
DNase I treated, and then reverse transcribed using 200 units of
Superscript RT (BRL) in the presence of 0.4 Wg random hexamers
(Boehringer), 10 mM DTT, 50 mM Tris-HCl pH 8.3, 75 mM KCl,
3 mM MgCl2, 0.5 mM dNTP-lithium salt (Boehringer) and 20 units of
RNase inhibitor (Promega). Incubation was at 37‡C for 10 min, fol-
lowed by 1 h at 42‡C. One ¢ftieth of ¢rst strand cDNA was used in
the PCR reaction. To test for contamination by genomic DNA, all
RNA samples were run in duplicate without addition of reverse tran-
scriptase.
The (CA)n repeat polymorphism of the mouse Igf2 gene [18] was
analyzed using the primers Igf2-A (5P-GAACTTAATTGGCA-
CAAGCCC-3P) and Igf2-B (5P-ACCATGCAAACTGCTCAGGA-
3P) or Igf2-C and Igf2-D (see above). The PCR reaction was carried
out in 25 Wl with 1 unit Taq DNA polymerase (Boehringer) using an
initial denaturation step of 2 min at 95‡C followed by 35 cycles at
94‡C for 1 min, 55‡C for 1 min and 72‡C for 1 min for primers A and
B and 94‡C for 30 s, 63‡C for 30 s and 72‡C for 30 s for primers C
and D. In both cases, a ¢nal elongation of 5 min at 72‡C terminated
the reactions. For allele visualization, PCR products were electro-
phoresed on denaturing 8% polyacrylamide-urea gel after including
a 32P-end labelled primer in the ampli¢cation.
The MspI RFLP of the H19 gene [19] was analyzed by PCR am-
pli¢cation using primers H19-A (5P-CACTGACCTTCTAAAC-
GAGG-3P) and H19-B (above) chosen from the nucleotide sequence
of the mouse gene [22]. Conditions with primers A and B were an
initial denaturation step of 2 min at 95‡C followed by 36 cycles at
94‡C for 30 s, 63‡C for 30 s and 72‡C for 30 s and a ¢nal extension at
72‡C for 5 min; the PCR products were internally labelled by per-
forming the PCR reactions in the presence of [K-32P]dGTP (Amer-
sham). For allele visualization, the PCR products were digested with
MspI and separated on non-denaturing 6% polyacrylamide gels.
All the numerical values were obtained by computer quantitation of
the image using a Molecular Dynamics phosphorimager.
3. Results
3.1. Relative levels of histone acetylation on paternal and
maternal alleles of the H19 and Igf2 genes
In order to study the role of histone acetylation in the
expression of the H19 and Igf2 genes we cultured ¢broblasts
(CUB) from a 3-day-old C57-Black6 (maternal)UBALB/c
(paternal) mouse and analyzed the relative levels of histone
acetylation on the paternal and maternal alleles in immuno-
precipitated chromatin. Chromatin was prepared from the
CUB cells and immunoprecipitated with antibodies raised
against acetylated amino-terminal tails of histone H3 or H4.
Fragments ranging from 115 to 150 bp and containing se-
quences which were polymorphic between BALB/c and C57-
Black6 strains were ampli¢ed by PCR and used to determine
the relative amounts of paternal and maternal alleles in the
immunoprecipitated nucleosomes (Fig. 1A). Control reactions
performed on ranges of stoichiometric mixtures of parental
DNAs ensured that, under the PCR conditions used, the ra-
tios of ¢nal products detected accurately re£ected the relative
concentrations of the alleles in the input DNA (Fig. 1B^D).
We ¢rst analyzed the chromatin acetylation of a region
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spanning a polymorphic MspI site present in the ¢rst exon of
the H19 gene (Fig. 1A and [19]). Equivalent amounts of pa-
ternal and maternal H19 alleles were ampli¢ed from the non-
immunoprecipitated nucleosomes (Fig. 1B, lane Co). How-
ever, the maternal, transcriptionally active H19 allele was
preferentially ampli¢ed with respect to the paternal allele in
the samples immunoprecipitated with both anti-acetylated H3
Fig. 2. E¡ect of inhibition of histone deacetylase activity on the im-
printing of the H19 and Igf2 genes. A: Analysis of the allele-speci¢c
expression of the H19 gene. RNA was puri¢ed from untreated
CUB cells (control) and cells treated with the histone deacetylase
inhibitors sodium butyrate (50 mM) or TSA (100 ng/ml), used for
cDNA synthesis and subjected to PCR ampli¢cation. The PCR
products obtained from genomic DNA and cDNAs with the pri-
mers H19-A and H19-B were digested with the polymorphic restric-
tion enzyme MspI and analyzed on 6% acrylamide gel. B: Analysis
of the allele-speci¢c expression of the Igf2 gene. Genomic DNA and
cDNAs prepared as in A were PCR ampli¢ed with the primers
Igf2-A and Igf2-B and electrophoresed on denaturing 8% polyacryl-
amide-urea gel. C: Dose-dependent e¡ect of TSA on Igf2 allelic ex-
pression. DNA and cDNA prepared from cells treated with increas-
ing doses of TSA (5, 10, 20, 50 and 100 ng/ml) were PCR ampli¢ed
with the primers Igf2-C and Igf2-D. To test for contamination by
genomic DNA, all RNA samples were run in duplicate with (+RT)
or without (3RT) the addition of reverse transcriptase.
Fig. 1. Relative histone acetylation levels of the paternal and mater-
nal alleles of the H19 and Igf2 genes. A: Structure of the mouse
Igf2/H19 region and location of polymorphisms. Exons are shown
as ¢lled boxes. Transcription start sites are indicated by bent ar-
rows. The (CA)n polymorphism and the RFLPs utilized in this
study are indicated by vertical arrows. B^D: Histone acetylation as-
say. Di¡erent input ratios of parental C57-Black6 and BALB/c
DNAs or DNA of CUB cells prepared from non-immunoprecipi-
tated, micrococcal nuclease-digested chromatin (C) or nucleosomes
immunoprecipitated with monoclonal antibody directed against acet-
ylated histone H3 (H3 IP) or H4 tails (H4 IP) were subjected to
PCR with primers speci¢c for the H19 MspI RFLP (B), the Igf2
(CA)n repeat (C) or the Igf2 AvaII RFLP (D). One radiolabelled
primer of each pair was included in the PCR. The paternal and ma-
ternal alleles were separated on denaturing 8% polyacrylamide-urea
gels and are indicated by arrows. Relative ampli¢cation of the pa-
rental alleles was calculated by computer quantitation of the gel fol-
lowing exposure to a phosphorimager.
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and H4 antibodies (Fig. 1B, lanes H3 IP and H4 IP). There-
fore, a strong di¡erence exists in the relative acetylation level
of the two parental H19 alleles in the ampli¢ed region, with
the silent paternal allele being hypoacetylated.
To investigate the chromatin acetylation state of the Igf2
gene, we ¢rst analyzed the 3P UTR, where a polymorphic
(CA)n repeat has been described between the BALB/c and
the C57-Black6 strains (Fig. 1A and [18]). As shown in Fig.
1C, the paternal and maternal Igf2 alleles were ampli¢ed with
similar e⁄ciency from control and immunoprecipitated sam-
ples, indicating that, at least in the 3P UTR, both the active
and silent Igf2 alleles are acetylated at comparable levels.
Because the 3P UTR polymorphic (CA)n repeat is located at
the 3P terminus of the transcript, we looked for polymor-
phisms closer to the transcription start site. The murine Igf2
gene is transcribed from two stronger (P2 and P3) and one
weaker promoter (P1, see [23]). A polymorphic AvaII site was
found 705 bp upstream of the start site of promoter P2 (Fig.
1A) which allowed analysis of histone acetylation in this re-
gion. As with the 3P UTR, paternal and maternal alleles were
similarly immunoprecipitated by anti-acetylated H3 and H4
antibodies (Fig. 1D), indicating that no major di¡erence exists
in the acetylation status between the active and silent Igf2
alleles also in the region immediately upstream of promoter
P2.
3.2. E¡ect of inhibition of histone deacetylases
The relevance of histone acetylation in determining the rel-
ative transcriptional activity of the paternal and maternal al-
leles of the H19 and Igf2 alleles was tested by analyzing the
e¡ects of the histone deacetylase inhibitors TSA and sodium
butyrate on the imprinting status of these genes in cultured
CUB cells.
RT-PCR ampli¢cation of the polymorphic sequences
present in the H19 and Igf2 transcripts showed that untreated
CUB cells maintained the imprinting of the H19 and Igf2
genes, as in the animal of origin (Fig. 2A,B, control lanes).
Treatment of the cells with 50 mM sodium butyrate or 100 ng/
ml TSA did not alter the imprinted expression of the H19
gene (Fig. 2A). In contrast, the same treatments caused a
signi¢cant relaxation of Igf2 imprinting, since both histone
deacetylase inhibitors reactivated the normally silent maternal
Igf2 allele (Fig. 2B). As shown in Fig. 2C, the e¡ect of TSA
on Igf2 imprinting was dose-dependent.
Fig. 3. E¡ect of inhibition of DNA methylation and histone deacetylase activity on the imprinting of the H19 and Igf2 genes. Analysis of the
allele-speci¢c expression of the H19 (A) and Igf2 (B) genes in untreated CUB cells (control), and cells treated with the histone deacetylase in-
hibitors sodium butyrate (50 mM) or TSA (100 ng/ml) alone, with the cytosine methylation inhibitor 5-azaC at a concentration of 100 WM
(Aza 100) and 200 WM (Aza 200), and with the combination of 5-azaC and sodium butyrate or 5-azaC and TSA. The paternal and maternal
alleles of the H19 and Igf2 genes were analyzed as in Fig. 2A,C.
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3.3. E¡ect of inhibition of DNA methylation
The heavily methylated status of the maternal H19 allele
observed in tissues and cultured cells, including the CUB
strain ([9,10,24] and data not shown), prompted us to inves-
tigate the e¡ect of coupling the inhibition of histone deacety-
lase activity to inhibition of DNA methylation. For this
purpose, CUB cells were incubated with increasing concen-
trations of the cytosine methylation inhibitor 5-azaC associ-
ated or not with the histone deacetylase inhibitors and the
relative expression of paternal and maternal H19 and Igf2
alleles was determined by RT-PCR, as described above.
Little or no e¡ect of 5-azaC treatment alone on the im-
printing status of the H19 gene was observed (Fig. 3A). How-
ever, combinations of 100 WM 5-azaC and 50 mM sodium
butyrate or 200 WM 5-azaC and 100 ng/ml TSA caused a
signi¢cant activation in the expression of the paternal relative
to the maternal H19 allele (Fig. 3A). Unlike the H19 gene,
a limited activation of the imprinted Igf2 allele was observed
in CUB cells also after treatment with 5-azaC alone, whereas
a more dramatic relaxation of Igf2 imprinting was
achieved by 5-azaC and sodium butyrate or TSA together
(Fig. 3B).
Overall, these data show that inhibition of both DNA
methylation and histone deacetylation in CUB cells caused
reactivation of the silent maternal allele of the Igf2 gene
and that the two e¡ects were additive. Additionally, treatment
with either DNA methylation or histone deacetylase inhibitors
alone did not a¡ect H19 imprinting, but the two kinds of
chemicals together had a synergistic e¡ect on the activation
of the imprinted allele of the H19 gene.
4. Discussion
Heritable epigenetic modi¢cations must control the unequal
expression of paternal and maternal alleles of the imprinted
genes in somatic tissues. Hypermethylation of the silent alleles
occurring on most, although not all, imprinted genes is likely
part of the mechanism involved in the maintenance of the
imprinting status, consistent with the suppressing activity of
this DNA modi¢cation on gene expression. Here we show
that the two alleles of the imprinted H19 gene display di¡erent
levels of histone acetylation in the region of the ¢rst exon. The
unexpressed and hypermethylated allele is associated with his-
tones with low levels of lysine acetylation. Conversely, chro-
matin at the expressed and undermethylated H19 allele is
hyperacetylated. Therefore, like heterochromatin and the in-
active X chromosome, the imprinted H19 allele has the typical
features of transcriptionally inactive DNA, i.e. CpG hyper-
methylation, closed chromatin conformation, and histone hy-
poacetylation. Svensson et al. [25] showed, by the allele-spe-
ci¢c in situ hybridization technique, that treatment of
embryos with the histone deacetylase inhibitor TSA reacti-
vated in a variegated manner the imprinted H19 allele in the
extraembryonic but not embryonic cells. We found that
growth in the presence of TSA alone did not exert a signi¢-
cant e¡ect on H19 imprinting in a population of cultured
somatic cells. Rather, a combination of reagents that counter-
acts both cytosine methylation and histone deacetylation is
required to activate the imprinted H19 allele. These results
indicate that both epigenetic modi¢cations participate in
maintenance of the imprinting status of this gene and that
alleviation of either modi¢cation individually is insu⁄cient
to allow reactivation of the imprinted H19 allele in somatic
cells.
The Igf2 gene does not display major allele-speci¢c di¡er-
ences in the level of histone acetylation, at least in the two 5P
£anking and 3P untranslated regions analyzed, but inhibition
of histone deacetylase activity causes relaxation of its imprint-
ing status. Recently, Hu et al. [26] have reported a similar
e¡ect of TSA and sodium butyrate on Igf2 imprinting in hu-
man cells. Although these results clearly indicate that histone
acetylation is involved also in the control of Igf2 imprinting,
they do not give any clue on how this is achieved. The com-
plex mechanism of regulation of this gene may possibly ex-
plain these ¢ndings. Igf2 shows only limited allele-speci¢c dif-
ferences in CpG methylation; unlike H19, methylation at
these sites is associated with the expressed rather than the
silent allele and it appears to be dispensable for gene expres-
sion [11,12,27]. Two cis-acting regulatory elements located
near H19 have been demonstrated so far to control the ex-
pression of the Igf2 gene. The more 3P one is an endoderm-
speci¢c enhancer activating Igf2 on the paternal chromosome
and H19 on the maternal homolog [14]. The second element
(di¡erentially methylated domain, DMD) is a region located
5P of the H19 gene, whose methylation status is preserved
throughout development on the maternal chromosome and
whose presence is required for both Igf2 and H19 imprinting
[15]. Two models have been proposed for how these two ele-
ments operate [2]. According to the ¢rst, the promoters of the
two genes compete for the same enhancer element(s) and the
methylation status of the H19 promoter determines which
gene is activated. The second model suggests that the DMD
is a chromatin insulator, which, if not methylated, interferes
with the activation of the Igf2 gene by the enhancer. In both
models, the inherited methylation status of the DMD could be
re£ected in the methylation state of the H19 promoter as well,
causing suppression of the maternal H19 allele. The absence
of major allele-speci¢c di¡erences in the histone acetylation
level of the nucleosomes associated with the Igf2 gene is con-
sistent with the ¢nding of open chromatin conformations on
both parental alleles [11] and is one additional line of evidence
indicating that the expression of the Igf2 alleles is dependent
on regulatory elements located far from its transcribed se-
quence. The histone deacetylase inhibitors could interfere
with the acetylation status of the nucleosomes associated
with distal elements rather than that of nucleosomes over
the Igf2 promoters or coding region itself. Alternatively, dif-
ferential acetylation of paternal and maternal alleles could be
limited to very few nucleosomes proximal to the transcription
start site, to only some of the lysine residues recognized by
our antibodies, could target proteins other than histones or
a¡ect other gene functions which indirectly control the im-
printing status [28^31]. Regulatory sequences located distal
to the Igf2 gene may also be involved in mediating the e¡ect
of 5-azaC on Igf2 imprinting, since the maternal Igf2 allele
appears demethylated even in its naturally silent state [11].
Consistent e¡ects of DNA methylation inhibitors on Igf2 ex-
pression have been reported by Eversole-Cire et al. [32] and
Hu et al. [33].
Recent evidence indicates that deregulation of histone acet-
ylase and deacetylase activity in human cancer is a frequent
event [34]. Relaxation of the imprinting status, resulting in the
doubling of the active gene dosage of the Igf2 gene, has also
been observed in a high number of human neoplasms [35^38].
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Our results suggest that the inhibition of the histone deacet-
ylases or the inappropriate activation of the histone acetyl-
transferases could be the mechanism causing the loss of Igf2
imprinting in human cancer. Also, the observed irreversibility
of the H19 imprinting in the presence of histone deacetylase
inhibitors alone in cultured mouse cells is consistent with the
infrequent occurrence of loss of H19 imprinting in human
cancer [36,39]. IGF-II, the protein product of the Igf2 gene,
is an important mitogen for tumor cells [40] and elucidation of
the mechanisms contributing to its activation may help ¢nd
new strategies for cancer therapy.
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